Subscribe To

Price Alert Latest News Economic Calendar News

DRRX / DURECT Corporation to Participate in Fireside Chat at the H.C. Wainwright BioConnect Investor Conference

CUPERTINO, Calif. , April 25, 2023 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that Dr. James Brown, President and CEO, will participate in a fireside chat hosted by Ed Arce, Managing Director, Senior Biotechnology Research Analyst, H.C Wainwright & Co., LLC at the H.C. Read More

Demo Live Account See Partner Details

Content Topics

Durect

Corporation

Participate

Fireside

Chat

Wainwright

Bioconnect

Investor

Conference

Stock

DRRX

Posted: Apr 25 2023, 18:45

Author Name: PRNewsWire

DRRX News

By InvestorPlace
October 2, 2023

3 Promising Biotech Stocks That Will Make Early Investors Rich

For investment ideas that can potentially lead to life-changing gains, few sectors are as viable as biotech stocks to make you rich. Fundamentally, th

By Seeking Alpha
May 8, 2023

DURECT Corporation (DRRX) Q1 2023 Earnings Call Transcript

DURECT Corporation (NASDAQ:DRRX ) Q1 2023 Earnings Conference Call May 8, 2023 4:30 PM ET Company Participants Tim Papp - Chief Financial Officer Jim

By PRNewsWire
May 1, 2023

DURECT Corporation to Announce First Quarter 2023 Financial Results and Provide Business Update on May 8

CUPERTINO, Calif. , May 1, 2023 /PRNewswire/ --- DURECT Corporation (Nasdaq: DRRX) today announced that it will report its first quarter 2023 financia

By PRNewsWire
April 25, 2023

DURECT Corporation to Participate in Fireside Chat at the H.C. Wainwright BioConnect Investor Conference

CUPERTINO, Calif. , April 25, 2023 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that Dr. James Brown, President and CEO, will par

By Zacks Investment Research
March 7, 2023

Durect (DRRX) Reports Q4 Loss, Tops Revenue Estimates

Durect (DRRX) delivered earnings and revenue surprises of 13.21% and 2.79%, respectively, for the quarter ended December 2022. Do the numbers hold clu

By PRNewsWire
February 28, 2023

DURECT Corporation to Announce Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 7

CUPERTINO, Calif. , Feb. 28, 2023 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it will report its fourth quarter and full ye

By Zacks Investment Research
January 11, 2023

Durect (DRRX) Soars 11.8%: Is Further Upside Left in the Stock?

Durect (DRRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the st

By Seeking Alpha
November 2, 2022

DURECT Corporation (DRRX) Q3 2022 Earnings Call Transcript

DURECT Corporation (NASDAQ:DRRX ) Q3 2022 Earnings Conference Call November 2, 2022 4:30 PM ET Company Participants Tim Papp - Chief Financial Officer

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.